Literature DB >> 18474296

Genomic structure of chromosome 17 deletions in BRCA1-associated ovarian cancers.

Karen M Chisholm1, Barbara A Goff, Rochelle Garcia, Mary-Claire King, Elizabeth M Swisher.   

Abstract

The aim of this study was to determine the genomic structure of the deletions on chromosome 17 in ovarian carcinomas from women with inherited BRCA1 mutations. Normal and tumor DNA from 14 ovarian tumors associated with inherited BRCA1 mutations were extracted and tested for loss of heterozygosity (LOH) at microsatellite markers along chromosome 17. Finer mapping using more microsatellite markers and single nucleotide polymorphisms helped further define the LOH margins. The genomic repeated elements within the LOH breakpoint regions were identified using the University of California Santa Cruz Genome Database, and the frequencies were compared to regions of equal GC percentages across the genome. Of the 14 ovarian tumors, 12 showed LOH of the entire chromosome 17. The other two tumors lost the distal end of the 17q arm. The breakpoints of these two tumors occurred in regions with significantly high frequencies of short interspersed nuclear elements (SINE), specifically Alu elements. Ovarian tumors of high grade and stage have large regions of LOH along chromosome 17, with most tumors showing loss of the entire chromosome. In those tumors with retention of part of chromosome 17, LOH margins suggest that a high Alu content may have a role in the deletions.

Entities:  

Mesh:

Year:  2008        PMID: 18474296      PMCID: PMC2413294          DOI: 10.1016/j.cancergencyto.2008.02.004

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  32 in total

1.  Hemizygous deletions of chromosome band 16q24 in Wilms tumor: detection by fluorescence in situ hybridization.

Authors:  P D Shearer; M B Valentine; P Grundy; J M DeCou; S D Banavali; H Komuro; D M Green; J B Beckwith; A T Look
Journal:  Cancer Genet Cytogenet       Date:  1999-12

2.  Loss of heterozygosity associated with uniparental disomy in breast carcinoma.

Authors:  Sabita K Murthy; Lisa M DiFrancesco; R Travis Ogilvie; Douglas J Demetrick
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

3.  Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera.

Authors:  Robert Kralovics; Yongli Guan; Josef T Prchal
Journal:  Exp Hematol       Date:  2002-03       Impact factor: 3.084

Review 4.  BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Authors:  P L Welcsh; M C King
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.

Authors:  B A Werness; S J Ramus; A S Whittemore; K Garlinghouse-Jones; I Oakley-Girvan; R A Dicioccio; Y Tsukada; B A Ponder; M S Piver
Journal:  Hum Pathol       Date:  2000-11       Impact factor: 3.466

6.  Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

Authors:  H A Risch; J R McLaughlin; D E Cole; B Rosen; L Bradley; E Kwan; E Jack; D J Vesprini; G Kuperstein; J L Abrahamson; I Fan; B Wong; S A Narod
Journal:  Am J Hum Genet       Date:  2001-02-15       Impact factor: 11.025

7.  Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.

Authors:  Christopher R E McEvoy; Alexander A Morley; Frank A Firgaira
Journal:  Genes Chromosomes Cancer       Date:  2003-07       Impact factor: 5.006

8.  Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH.

Authors:  Ofir Israeli; Walter H Gotlieb; Eitan Friedman; Boleslaw Goldman; Gilad Ben-Baruch; Ayala Aviram-Goldring; Shlomit Rienstein
Journal:  Gynecol Oncol       Date:  2003-09       Impact factor: 5.482

9.  BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.

Authors:  Susan J Ramus; Paul D P Pharoah; Patricia Harrington; Carole Pye; Bruce Werness; Lynda Bobrow; Ayse Ayhan; Dagan Wells; Ami Fishman; Martin Gore; Richard A DiCioccio; M Steven Piver; Alice S Whittemore; Bruce A J Ponder; Simon A Gayther
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

10.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Authors:  Tom Walsh; Silvia Casadei; Kathryn Hale Coats; Elizabeth Swisher; Sunday M Stray; Jake Higgins; Kevin C Roach; Jessica Mandell; Ming K Lee; Sona Ciernikova; Lenka Foretova; Pavel Soucek; Mary-Claire King
Journal:  JAMA       Date:  2006-03-22       Impact factor: 56.272

View more
  4 in total

1.  Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers.

Authors:  I Brozek; K Ochman; J Debniak; L Morzuch; M Ratajska; M Stepnowska; M Stukan; J Emerich; J Limon
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

2.  Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.

Authors:  Elżbieta Złowocka-Perłowska; Aleksandra Tołoczko-Grabarek; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2022-01-04       Impact factor: 2.857

3.  Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer.

Authors:  Yixuan Cen; Yifeng Fang; Yan Ren; Shiyuan Hong; Weiguo Lu; Junfen Xu
Journal:  Cell Death Dis       Date:  2022-04-13       Impact factor: 8.469

4.  BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance.

Authors:  Yifan Wang; Andrea J Bernhardy; Joseph Nacson; John J Krais; Yin-Fei Tan; Emmanuelle Nicolas; Marc R Radke; Elizabeth Handorf; Alba Llop-Guevara; Judith Balmaña; Elizabeth M Swisher; Violeta Serra; Suraj Peri; Neil Johnson
Journal:  Nat Commun       Date:  2019-12-11       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.